Accu-Tell® COVID-19 IgG/IgM Rapid Test Available Now
1. Accu-Tell® COVID-19 IgG/IgM Rapid Test is for professional use. It is NOT for self-testing or home use;
2. Any distributor shall notify to your local authority about the product and get the appropriate approval before you import and place the product in your local market;
3. We are not marketing, selling, or distributing Accu-Tell® COVID-19 IgG/IgM Rapid Test without FDA clearance in USA.
The ongoing outbreak of the novel coronavirus disease (COVID-191) was first reported in Wuhan, China on Dec. 31, 2019. As of 20 February 2020, a cumulative total of 75,465 COVID-19 cases were reported in China. COVID-19 is transmitted via droplets and fomites during close unprotected contact between an infector and infectee.
From the outbreak of the disease, our R & D team has been dedicated to developing the colloidal gold antibody detection kits for COVID-19. Now, Accu-Tell® COVID-19 IgG/IgM Test cassette is available for qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in human whole blood, serum or plasma. Our test kit just needs 10ul serum, plasma or whole blood, and the results can be read within 10 minutes. It can quickly screen the patients and lower the false negative rate of PCR. It’s very helpful to control the disease, reduce the spread of virus and avoid cross infection. As it is Flu season in many areas, we strongly recommend to use our Accu-Tell® COVID-19 IgG/IgM test together with our Accu-Tell® Influenza A&B test, so as to differentiate these two diseases quickly.
Now, we are ready to produce and deliver such rapid tests to our distributors worldwide. Thanks to the effective control measures, all our staff and our families are safe and healthy. Our daily office work and routine production have recovered gradually from the middle of Feb.
If you need any information about our products or any information about the disease, pls feel free to contact us.
“Once again, our key message is: test, test, test.”
Mar. 19, 2020